Cholesterol affects gene expression of the Jun family in colon carcinoma cells using different signaling pathways

Molecular and Cellular Endocrinology

Volumn 374, Issue 1-2, 2013, Pages 101-107

  Scheinman, Eyal J ^a   Rostoker, Ran ^a   LeRoith, Derek ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cholesterol; Colon cancer cells; Jun gene expression

Indexed keywords

CHOLESTEROL; CXCL1 CHEMOKINE; METHYL BETA CYCLODEXTRIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN C JUN; TRANSCRIPTION FACTOR JUNB; VANADIC ACID; WORTMANNIN;

ANIMAL CELL; ARTICLE; C JUN GENE; COLON CARCINOMA; CONTROLLED STUDY; CXCL 1 GENE; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENE IDENTIFICATION; JUN B GENE; LIPID RAFT; MOUSE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANDROSTADIENES; ANIMALS; BETA-CYCLODEXTRINS; CELL LINE, TUMOR; CHEMOKINE CXCL1; CHOLESTEROL; COLON; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MEMBRANE MICRODOMAINS; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; VANADATES;

EID: 84878686472     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.04.011     Document Type: Article

References (32)

1. Ahmed R.L., Schmitz K.H., Anderson K.E., Rosamond W.D., Folsom A.R. The metabolic syndrome and risk of incident colorectal cancer. Cancer 2006, 107:28-36.
2. Alikhani N., Ferguson R.D., Novosyadlyy R., Gallagher E.J., Scheinman E.J., Yakar S., Leroith D. Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model. Oncogene 2013, 32:961-967.
3. Bielecka-Dabrowa A., Hannam S., Rysz J., Banach M. Malignancy-associated dyslipidemia. Open Cardiovasc. Med. J. 2011, 5:35-40.
4. Broitman S.A., Cerda S., Wilkinson J.t. Cholesterol metabolism and colon cancer. Prog. Food Nutr. Sci. 1993, 17:1-40.
5. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. New Engl. J. Med. 2003, 348:1625-1638.
6. Demarin V., Lisak M., Morovic S. Mediterranean diet in healthy lifestyle and prevention of stroke. Acta clinica Croatica 2011, 50:67-77.
7. Edidin M. Lipids on the frontier: a century of cell-membrane bilayers. Nature Rev. Mol. Cell Biol. 2003, 4:414-418.
8. Eliassen A.H., Hankinson S.E. Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv. Exp. Med. Biol. 2008, 630:148-165.
9. Fraser G.E. Vegetarian diets: what do we know of their effects on common chronic diseases?. The American journal of clinical nutrition 2009, 89:1607S-1612S.
10. Freeman M.R., Solomon K.R. Cholesterol and prostate cancer. J. Cell. Biochem. 2004, 91:54-69.
11. Frezza E.E., Wachtel M.S., Chiriva-Internati M. Influence of obesity on the risk of developing colon cancer. Gut 2006, 55:285-291.
12. Gal D., MacDonald P.C., Porter J.C., Simpson E.R. Cholesterol metabolism in cancer cells in monolayer culture. III. Low-density lipoprotein metabolism. Int. J. Cancer 1981, 28:315-319.
13. Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol. Clin. North America 2002, 31:925-943.
14. Huxley R., Lewington S., Clarke R. Cholesterol, coronary heart disease and stroke: a review of published evidence from observational studies and randomized controlled trials. Semin. Vasc. Med. 2002, 2:315-323.
15. Jacobs R., Voorneveld P., Kodach L., Hardwick J. Cholesterol metabolism and colorectal cancers. Curr. Opin. Pharmacol. 2012, 12:690-695.
16. Karin M., Gallagher E. From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance. IUBMB life 2005, 57:283-295.
17. Keys A., Aravanis C., Blackburn H., Buzina R., Dontas A.S., Fidanza F., Karvonen M.J., Menotti A., Nedeljkovic S., Punsar S., et al. Serum cholesterol and cancer mortality in the Seven Countries Study. Am J Epidemiol 1985, 121:870-883.
18. Kim J.H., Lim Y.J., Kim Y.H., Sung I.K., Shim S.G., Oh S.O., Park S.S., Yang S., Son H.J., Rhee P.L., Kim J.J., Rhee J.C., Choi Y.H. Is metabolic syndrome a risk factor for colorectal adenoma?. Cancer Epidemiol. Biomarkers Prev. 2007, 16:1543-1546.
19. Kim S., Han J., Lee D.H., Cho K.H., Kim K.H., Chung J.H. Cholesterol, a major component of caveolae, down-regulates matrix metalloproteinase-1 expression through ERK/JNK pathway in cultured human dermal fibroblasts. Ann. Dermatol. 2010, 22:379-388.
20. Kudo Y., Iizuka S., Yoshida M., Tsunematsu T., Kondo T., Subarnbhesaj A., Deraz E.M., Siriwardena S.B., Tahara H., Ishimaru N., Ogawa I., Takata T. Matrix metalloproteinase-13 (MMP-13) directly and indirectly promotes tumor angiogenesis. J. Biol. Chem. 2012, 287:38716-38728.
21. Lim Y.J., Kim J.H., Park S.K., Son H.J., Kim J.J., Kim Y.H. Hyperhomocysteinemia is a risk factor for colorectal adenoma in women. J. Clin. Biochem. Nutr. 2012, 51:132-135.
22. Markowitz S.D., Myeroff L., Cooper M.J., Traicoff J., Kochera M., Lutterbaugh J., Swiriduk M., Willson J.K. A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene. J. Clin. Invest. 1994, 93:1005-1013.
23. Milligan G. An examination of the effect of six types of error perturbation on fifteen clustering algorithms. Psychometrika 1980, 45:325-342.
24. Oh H.Y., Lee E.J., Yoon S., Chung B.H., Cho K.S., Hong S.J. Cholesterol level of lipid raft microdomains regulates apoptotic cell death in prostate cancer cells through EGFR-mediated Akt and ERK signal transduction. The Prostate 2007, 67:1061-1069.
25. Ordovas J.M., Kaput J., Corella D. Nutrition in the genomics era: cardiovascular disease risk and the Mediterranean diet. Molecular nutrition & food research 2007, 51:1293-1299.
26. Parkin D.M., Pisani P., Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer 1999, 80:827-841.
27. Pontes Soares C., Portilho D.M., da Silva Sampaio L., Einicker-Lamas M., Morales M.M., Costa M.L., Dos Santos Mermelstein C. Membrane cholesterol depletion by methyl-beta-cyclodextrin enhances the expression of cardiac differentiation markers. Cells Tissues Organs 2010, 192:187-199.
28. Samuels Y., Wang Z., Bardelli A., Silliman N., Ptak J., Szabo S., Yan H., Gazdar A., Powell S.M., Riggins G.J., Willson J.K., Markowitz S., Kinzler K.W., Vogelstein B., Velculescu V.E. High frequency of mutations of the PIK3CA gene in human cancers. Science 2004, 304:554.
29. Tsao H., Goel V., Wu H., Yang G., Haluska F.G. Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma. J. Invest. Dermatol. 2004, 122:337-341.
30. Verbeke H., Struyf S., Laureys G., Van Damme J. The expression and role of CXC chemokines in colorectal cancer. Cytokine Growth Factor Rev. 2011, 22:345-358.
31. Wang P.Y., Liu P., Weng J., Sontag E., Anderson R.G. A cholesterol-regulated PP2A/HePTP complex with dual specificity ERK1/2 phosphatase activity. EMBO J. 2003, 22:2658-2667.
32. Zhuang L., Kim J., Adam R.M., Solomon K.R., Freeman M.R. Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J. Clin. Invest. 2005, 115:959-968.